In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Bluebird bio Inc (NASDAQ: BLUE) was $0.47 for the day, up 0.43% from the previous closing price of $0.46. In other words, the price has increased by $0.43 from its previous closing price. On the day, 3.43 million shares were traded. BLUE stock price reached its highest trading level at $0.4862 during the session, while it also had its lowest trading level at $0.4601.
Ratios:
Our analysis of BLUE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.68. In the meantime, Its Debt-to-Equity ratio is 7.37 whereas as Long-Term Debt/Eq ratio is at 3.67.
Morgan Stanley Upgraded its Underweight to Equal-Weight on December 08, 2023, whereas the target price for the stock was revised from $3 to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 30 ’24 when Klima Thomas J sold 1,006 shares for $0.53 per share. The transaction valued at 529 led to the insider holds 170,000 shares of the business.
Obenshain Andrew sold 34,780 shares of BLUE for $18,270 on Sep 30 ’24. The President and CEO now owns 375,218 shares after completing the transaction at $0.53 per share. On Sep 30 ’24, another insider, Obenshain Andrew, who serves as the Officer of the company, bought 34,780 shares for $0.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLUE now has a Market Capitalization of 90363920 and an Enterprise Value of 341936736. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.65 while its Price-to-Book (P/B) ratio in mrq is 1.71. Its current Enterprise Value per Revenue stands at 6.228 whereas that against EBITDA is -1.132.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $5.53, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -11.43%, while the 200-Day Moving Average is calculated to be -50.77%.
Shares Statistics:
BLUE traded an average of 7.32M shares per day over the past three months and 3575910 shares per day over the past ten days. A total of 192.77M shares are outstanding, with a floating share count of 192.36M. Insiders hold about 0.80% of the company’s shares, while institutions hold 42.46% stake in the company. Shares short for BLUE as of 1728950400 were 49415844 with a Short Ratio of 6.75, compared to 1726185600 on 48403895. Therefore, it implies a Short% of Shares Outstanding of 49415844 and a Short% of Float of 27.61.
